Andelyn Biosciences

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy

The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients

Andelyn Biosciences selected as viral vector manufacturing partner for FNIH, AMP and BGTC

Andelyn has been selected to optimise and scale the AAV therapy processes for the treatments of CNGB1 Retinitis Pigmentosa 45 and NPHP5 retinal degeneration
Research & Development

Andelyn and Ohio State collaborate for preclinical and GMP production of novel gene therapies

Andelyn Biosciences, a pioneering and patient-focused cell and gene therapy contract development and manufacturing organisation (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacture of novel gene therapies
Manufacturing

Andelyn partners with Odylia on novel gene therapy

The partnership is set to treat vision loss caused by mutations in the RPGRIP1 gene
Manufacturing

Andelyn to manufacture gene therapy for infantile neuroaxonal dystrophy

The disease leads to neurodegeneration in the nervous system of patients accompanied by an inflammatory response and causes progressive loss of mental skills, muscular control, and vision
Drug Delivery

Andelyn Biosciences opens GMP manufacturing facility

This investment is the latest execution of Andelyn’s Biosciences’ growth plan after its launch and opening of the GMP Andelyn Plasmid Core (APC)
Subscribe now